Faeth Therapeutics, Inc. (FTH) KPIs and segments

FTHNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 7/30

$10.65−2.70 (-20.22%)

Close on Nov 12, 2026Market cap $275.20MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Faeth Therapeutics's business

Coming soon

This tab will track the numbers specific to Faeth Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?